Understanding the Underlying Pathophysiology of Erythropoietic Protoporphyria

Erythropoietic protoporphyria (EPP) is a rare inherited metabolic disorder rooted in a single enzymatic deficiency. In the first episode of this Dermatology Times Expert Persectives video series, Elizabeth Buzney, MD, a dermatologist at Brigham and Women's Hospital and part of Mass General Brigham Dermatology in Boston, Massachusetts, describes the cascade that drives the condition: patients lack adequate ferrochelatase, the enzyme responsible for heme synthesis. Without sufficient ferrochelatase activity, protoporphyrins accumulate in red blood cells, plasma, skin, and the liver.

The consequences become clinically apparent because protoporphyrin is highly reactive to light. "When EPP patients are exposed to light, particularly blue light, they get phototoxic symptoms," Buzney explains, noting that reactions manifest as intense burning, tingling, and itching of exposed skin, followed by redness, swelling, and—with repeated long-term exposure—permanent scarring.

A Pain Disproportionate to What Clinicians See

According to Buzney, one of the most diagnostically confounding features of EPP is the mismatch between the severity of a patient's reported symptoms and the absence of visible skin findings. Buzney emphasized that the pain is characteristically deep rather than superficial. "The pain is described as a deep burning, not really a surface burning — and it's very disproportionately severe pain relative to what you see on the skin," she said. "You may see nothing on the skin at all."

This disconnect creates significant barriers to timely diagnosis. Children presenting with extreme pain after outdoor activity but no visible skin changes may be doubted by parents, coaches, and clinicians alike. "Sometimes they may even think that the child is malingering, trying to get out of a sports event," Buzney noted, "but really they're having this intense, painful reaction."

Triggers Beyond Sunlight

While outdoor sun exposure is the most common trigger, Buzney stresses that EPP reactions are not limited to sunlight. Visible indoor light, fluorescent office lighting, and even surgical suite illumination can provoke episodes—a critical consideration for patients undergoing procedures.

Reactions can be prolonged and debilitating. "A reaction can last days to weeks," Buzney explained, "and further exposure to light and other physical stimuli can actually make it much worse." Crucially, standard pain and burn management approaches provide little relief, leaving patients with no option but to remain indoors in darkness until symptoms subside. "Children can't be comforted by their parents, and adults are incapacitated," she said.

Diagnostic Delays and Misattribution

Because phototoxic pain presents rapidly, often within minutes of light exposure. and visible skin changes may be absent entirely, EPP is frequently misattributed to allergic reactions or environmental triggers. Extensive allergy workups typically return negative results, further delaying diagnosis. Patients themselves may not initially connect their symptoms to light, instead searching for other explanations. "They may be trying to find another trigger," Buzney observed, "but it's really the light itself."

Clinicians who understand EPP's characteristic presentation of rapid-onset deep burning pain, minimal or absent cutaneous findings, and unresponsiveness to conventional analgesia, are better positioned to pursue appropriate diagnostic evaluation and spare patients years of unnecessary suffering.